BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2493720)

  • 1. Transplantation in hyperimmunized patients.
    Claas FH; van Rood JJ
    Adv Nephrol Necker Hosp; 1989; 18():317-23. PubMed ID: 2493720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of the frequency of anti-HLA hyperimmunization in patients with kidney transplantation].
    Pongratz G; Goumaz C; Gore SM; Bradley BA; Jeannet M
    Schweiz Med Wochenschr; 1990 Sep; 120(37):1335-8. PubMed ID: 2218455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptable HLA mismatches for highly immunized patients.
    Claas FH; De Meester J; Witvliet MD; Smits JM; Persijn GG; Doxiadis II
    Rev Immunogenet; 1999; 1(3):351-8. PubMed ID: 11256426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of highly sensitized patients: capitol medical center experience.
    Amante AJ; Ejercito R
    Transplant Proc; 2008 Sep; 40(7):2274-80. PubMed ID: 18790211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperimmunized patients awaiting cadaveric kidney graft: is there a quick desensitization possible?
    Faenza A; Fuga G; Bertelli R; Scolari MP; Buscaroli A; Stefoni S
    Transplant Proc; 2008; 40(6):1833-8. PubMed ID: 18675064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates.
    Duquesnoy RJ; Witvliet M; Doxiadis II; de Fijter H; Claas FH
    Transpl Int; 2004 Jan; 17(1):22-30. PubMed ID: 12955350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
    Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
    Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients.
    Duquesnoy RJ; Howe J; Takemoto S
    Transplantation; 2003 Mar; 75(6):889-97. PubMed ID: 12660520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney transplantation in the United States.
    Cecka JM
    Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SEOPF high-grade match algorithm: the effect of HLA matching with ROP trays in transplanting highly sensitized patients. Southern Organ Procurement Foundation.
    Tardif GN; McCalmon RT
    Clin Transplant; 1996 Dec; 10(6 Pt 2):594-7. PubMed ID: 8996748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Desensitization protocols in immunized living donor kidney transplant recipients].
    Nocera A
    G Ital Nefrol; 2009; 26(4):499-515. PubMed ID: 19644839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extending options for highly sensitized patients to receive a suitable kidney graft.
    Doxiadis II; Duquesnoy RJ; Claas FH
    Curr Opin Immunol; 2005 Oct; 17(5):536-40. PubMed ID: 16084709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of special programs for kidney transplantation of highly sensitized patients in Eurotransplant.
    Doxiadis II; De Meester J; Smits JM; Witvliet M; de Lange P; Persijn GG; Claas FH
    Clin Transpl; 1998; ():115-20. PubMed ID: 10503090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A special strategy to increase the chance of finding cross-match negative kidneys for highly sensitized patients.
    Claas FH; Gijbels Y; van der Velden-de Munck JJ; de Waal LP; D'Amaro J; Hendriks GF; Persijn GG; van Rood JJ
    Transplant Proc; 1988 Oct; 20(5):947-8. PubMed ID: 3055538
    [No Abstract]   [Full Text] [Related]  

  • 16. Desensitization strategies enabling successful renal transplantation in highly sensitized patients.
    Beimler JH; Susal C; Zeier M
    Clin Transplant; 2006; 20 Suppl 17():7-12. PubMed ID: 17100695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients.
    van den Berg-Loonen EM; Billen EV; Voorter CE; van Heurn LW; Claas FH; van Hooff JP; Christiaans MH
    Transplantation; 2008 Apr; 85(8):1086-90. PubMed ID: 18431226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological profile of patients awaiting a renal transplant.
    Díaz I; Sánchez P; Alonso C; Valdés F
    Clin Transplant; 2004 Oct; 18(5):529-35. PubMed ID: 15344955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
    Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
    Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.